Baldeep Mann
Internal Medicine · New York, NYNPI 1013438837
Payments from drug & device makers
Across 17 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$59
- Dynavax Technologies Corporation$48
- Novo Nordisk$46
- AstraZeneca$43
- Astellas Pharma US Inc$42
- Johnson & Johnson$38
- plus $92 from 5 others
What the payments were for
- Food & beverage$368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $59 |
| Dynavax Technologies Corporation | 3 | $48 |
| Novo Nordisk | 2 | $46 |
| AstraZeneca | 1 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Johnson & Johnson | 2 | $38 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $33 |
| Alkermes, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Coloplast | 1 | $13 |
| Pfizer | 1 | $11 |
How this compares
$368 in reported general payments places this provider in the 55th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $713 |
| Gabapentin | 26 | $508 |
| Atorvastatin Calcium | 65 | $411 |
| Pantoprazole Sodium | 18 | $391 |
| Rosuvastatin Calcium | 20 | $352 |
| Lactulose | 17 | $266 |
| Carvedilol | 23 | $209 |
| Amlodipine Besylate | 39 | $174 |
| Losartan Potassium | 31 | $172 |
| Lisinopril | 34 | $158 |
| Metformin Hcl | 14 | $117 |
| Omeprazole | 15 | $82 |
| Montelukast Sodium | 14 | $75 |
| Levothyroxine Sodium | 19 | $59 |
| Metoprolol Tartrate | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- James GreenwaldNew York$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.